Parsewise vs Certara (Synchrogenix) for Regulatory Submissions

Certara is a biosimulation and regulatory science company. Its Synchrogenix division provides technology and services for regulatory document authoring, submission publishing, and regulatory operations. Synchrogenix offers AI-powered tools for automating clinical study report (CSR) narratives, generating submission-ready documents, and managing eCTD publishing. Certara brings decades of regulatory science expertise: many of its staff are former regulatory affairs professionals, and its consulting arm advises on submission strategy. The company serves pharma, biotech, and medical device companies across the product lifecycle.

Parsewise is a decision platform that ingests entire document packages and reasons across them. For regulatory submissions, Parsewise processes CTD modules, clinical reports, CMC documentation, and related files as a single corpus, detecting cross-document inconsistencies and producing structured analytical outputs with word-level source attribution. Extraction agents are configured with natural-language instructions, allowing regulatory teams to define their own review criteria without adopting a vendor-imposed schema.

Both platforms process regulatory documents. The overlap is significant but the approaches differ: Certara brings deep regulatory domain expertise with purpose-built authoring and publishing tools; Parsewise offers broader document intelligence capabilities with configurable workflows that adapt to each organization’s process.

Methodology

Feature claims for Certara and Synchrogenix are based on publicly available vendor documentation, product pages, press releases, and published case studies as of April 2026. Parsewise capabilities are drawn from the current platform. We update this page periodically; check the “Page last modified” date at the bottom of this page for freshness.

Capability Comparison

Capability Certara (Synchrogenix) Parsewise
Primary function Regulatory document authoring, submission publishing, regulatory operations Decision platform: cross-document reasoning across regulatory dossiers
CSR authoring Core strength; AI-assisted narrative generation for clinical study reports Not an authoring tool; processes existing CSRs for cross-document analysis
eCTD publishing Full submission publishing with health authority format validation Not a publishing tool; analyzes submission content
Cross-document reasoning Limited to authoring context (e.g., pulling data into CSR templates) Native: links data across CTD modules, detects contradictions between documents
Inconsistency detection Relies on manual QC processes and editorial review Flags conflicting values, claims, and data across documents with exact source citations
Regulatory domain models Deep; CSR templates, submission type schemas, regulatory terminology databases No pre-built regulatory models; agents configured in natural language to match any process
Document authoring Integrated authoring with regulatory templates, review workflows, and version control Not an authoring tool; analytical layer for existing documents
Extraction approach Template-driven; structured around regulatory document types Template-free extraction agents configured with natural-language instructions
Consulting services Embedded regulatory science consulting for submission strategy Technology platform only; no regulatory consulting
Corpus scale Per-document authoring and review 25,000+ pages per run with exhaustive cross-document processing
Source attribution Document version tracking and editorial audit trails Word-level bounding boxes with page and paragraph references
Deployment Cloud-based SaaS Cloud, VPC, on-premises with regional data residency
Language support Multi-language regulatory document support 70+ languages, including mixed-language document packages
Security Enterprise security; specific certifications vary by product SOC 2 Type II, GDPR, TLS 1.2+, AES-256; no training on customer data
Conversational interface Not available Navi: conversational agent creation and querying

Key Differentiators

Regulatory authoring vs regulatory analysis

Certara’s Synchrogenix platform generates regulatory documents. Its AI tools automate portions of CSR narrative writing, pulling data from clinical databases and structuring it according to ICH E3 guidelines. The platform also handles submission compilation, eCTD formatting, and publishing to health authorities. This is document production: taking raw data and producing submission-ready content.

Parsewise does not produce regulatory documents. It reads them and reasons across them. The platform’s value appears after documents are drafted: detecting inconsistencies between a CSR’s narrative and the underlying clinical data, flagging contradictions between Module 2 summaries and Module 3 quality specifications, and verifying that safety reporting is consistent across modules. This analytical layer complements the authoring workflow that Certara provides. For a technical explanation of cross-document reasoning, see Cross-Document Reasoning.

Domain expertise vs platform flexibility

Certara has decades of regulatory science knowledge embedded in its products and services. CSR templates follow ICH guidelines. Submission workflows mirror FDA, EMA, and PMDA requirements. Regulatory terminology databases ensure consistent language. This domain depth means Certara’s tools work well for standard submission types within established regulatory frameworks.

Parsewise trades domain-specific depth for configurability. Its extraction agents accept natural-language instructions that define what to extract and how to structure it. A regulatory team working on a biosimilar submission can configure agents that reflect the specific comparative data requirements for that product type. A team preparing a cell therapy BLA can define quality dimensions that reflect the unique CMC considerations for living cell products. This flexibility matters when the regulatory framework itself is evolving, or when an organization’s internal processes do not align with a vendor’s predefined templates.

The trade-off is clear: Certara provides a faster path for standard submissions because the regulatory knowledge is already built in. Parsewise provides a more adaptable path for teams whose needs do not fit standard templates or whose processes are organizationally specific.

Services-embedded vs technology-only

Certara’s business model includes both technology and professional services. Synchrogenix offers regulatory consulting, medical writing, and submission management alongside its software. For companies (particularly smaller biotech) that lack in-house regulatory expertise, this bundled model provides both the tools and the people to use them.

Parsewise is a technology platform. It provides the analytical engine but does not offer regulatory consulting services. Organizations using Parsewise need internal regulatory expertise or external consultants to interpret findings and make submission decisions. For larger pharma companies with established regulatory affairs departments, this is not a limitation. For pre-commercial biotech, Certara’s services model may be more appropriate.

Cross-document inconsistency detection at scale

Certara’s authoring tools include quality control steps: editorial review, template validation, and consistency checks within the authoring workflow. These checks are valuable but operate primarily at the individual document level and rely on reviewer judgment for cross-document consistency.

Parsewise processes the entire dossier as a single corpus and systematically identifies inconsistencies across documents. When a manufacturing process change in Module 3 affects stability data, Parsewise can flag whether the corresponding Module 2 summary has been updated. When clinical efficacy claims appear in Module 2, Parsewise can verify them against the source data in Module 5 study reports. This inconsistency detection scales with dossier size; the number of cross-references that Parsewise checks grows with the corpus, while manual reviewer attention does not.

When to Choose Certara (Synchrogenix)

  • Your primary need is regulatory document authoring, particularly CSR narrative generation
  • You require eCTD publishing with validated output for global health authorities
  • You want regulatory consulting services bundled with technology
  • Your submissions follow standard regulatory frameworks (ICH, eCTD) and your processes align with Certara’s templates
  • You are a smaller biotech that needs both tools and regulatory expertise
  • Your team values regulatory-specific AI that uses domain terminology and standard templates

When to Choose Parsewise

  • You need to detect cross-module inconsistencies across a full regulatory dossier before submission
  • Your team has specific review criteria that do not fit into pre-built regulatory templates
  • You work on novel submission types (biosimilars, cell therapies, combination products) where regulatory frameworks are still developing
  • You want to configure analysis agents using natural-language instructions that match your team’s internal process
  • You need word-level source attribution linking every finding to its exact location in the source document
  • You require VPC or on-premises deployment with SOC 2 Type II and GDPR compliance
  • You already have regulatory authoring tools and need an analytical layer on top

Verdict

Certara and Parsewise occupy different positions in the regulatory document workflow. Certara is a regulatory document production platform: it helps teams author, compile, and publish submissions. Its regulatory science expertise is a genuine competitive advantage that Parsewise does not replicate. For standard submission types where the regulatory path is well-defined, Certara’s templates and domain knowledge accelerate the authoring process.

Parsewise is a regulatory document analysis platform: it reads existing documents and finds problems. Its cross-document reasoning surfaces inconsistencies that manual review may miss, particularly in large dossiers where data points must be consistent across hundreds of pages and multiple modules. The platform’s configurable ontology makes it useful for regulatory teams whose processes are unique or whose submission types are novel.

The strongest combined workflow uses Certara for authoring and Parsewise for pre-submission quality review. Certara produces the submission documents; Parsewise reviews the complete dossier for cross-module consistency before the submission goes to the health authority. This layered approach addresses both production efficiency and quality assurance.

For a broader comparison that includes Veeva and IQVIA, see Parsewise vs Veeva vs Certara vs IQVIA for Life Science Regulatory. For more on Parsewise’s approach to the life science vertical, see AI for Life Science Regulatory Document Intelligence.

Frequently Asked Questions

Can Parsewise generate clinical study reports like Certara?

No. Parsewise does not author documents. It processes existing documents and reasons across them. For CSR narrative generation, Certara’s Synchrogenix platform is purpose-built for that task. Parsewise’s role is analytical: reviewing the finished CSR against underlying clinical data for consistency.

Does Certara offer cross-document inconsistency detection?

Certara’s authoring tools include editorial review and template validation workflows. These are quality control measures within the authoring process. Systematic cross-document inconsistency detection across the full dossier (the kind that processes Module 2, 3, 4, and 5 as a single corpus) is not a core Certara capability. This is where Parsewise’s analytical layer adds value.

Is Parsewise suitable for regulatory submissions without Certara or Veeva?

Yes. Parsewise does not depend on any specific authoring or content management system. Regulatory teams can upload documents from any source (file systems, SharePoint, document management platforms) and run cross-document analysis. The platform processes the documents regardless of how they were authored or managed.

How does Parsewise handle the ICH CTD structure?

Parsewise does not enforce the CTD module structure. Instead, extraction agents can be configured to understand and analyze documents according to CTD module relationships. A team can instruct agents to compare Module 2 summaries against Module 3 quality data, or verify Module 5 clinical claims against specific study endpoints. The analysis reflects the CTD structure without requiring rigid adherence to a predefined template.

Which platform is better for a company preparing its first IND filing?

For first-time filers, Certara’s combination of authoring tools and regulatory consulting services provides both the technology and the expertise needed to navigate an unfamiliar process. Parsewise adds the most value when there is already a draft dossier to review for cross-module consistency. For early-stage companies without established regulatory processes, Certara’s services model is typically the better starting point.

Ready to see Parsewise in action? Request a demo or contact sales to discuss your use case.

Sources